Lead Product(s) : Yttrium Radioisotopes
Therapeutic Area : Oncology
Study Phase : Approved FDF
Sponsor : Grand Pharmaceutical Group Limited
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : SIR-Spheres Y-90 resin microspheres is the first therapeutic radiopharmaceutical approved by the NMPA based on clinical trial data, for the treatment of patients with colorectal cancer liver metastases.
Product Name : SIR-Spheres Y-90
Product Type : Radiolabelled Compounds
Upfront Cash : Inapplicable
September 02, 2022
Lead Product(s) : Yttrium Radioisotopes
Therapeutic Area : Oncology
Highest Development Status : Approved FDF
Sponsor : Grand Pharmaceutical Group Limited
Deal Size : Inapplicable
Deal Type : Inapplicable